Henry Schein

Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution, and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, laboratory, small and large equipment repair services, branded and generic pharmaceuticals, vaccines, surgicals, diagnostic tests, infection-control products and vitamins. The Technology & Value-Added Services segment offers financial on a non-recourse basis, network and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.

Earnings data Q2 2023

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, laboratory, small and large equipment repair services, branded and generic pharmaceuticals, vaccines, surgical, diagnostic tests, infection-control products, and vitamins. The Technology and Value-Added Services segment offers financial on a non-recourse basis, network, and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein to participate in three investor conferences.

Henry Schein to Participate in Three Investor Conferences

Henry Schein (HSIC) is expected to witness a favorable share price movement, led by optimism surrounding the performance of the dental business and strategic buyouts.

Here's Why Investors Should Retain Henry Schein (HSIC) for Now

Henry Schein has seen less impressive growth in recent years, as valuation multiples have compressed in response to this slower growth. Valuations have come down to about 14 times earnings, while leverage is low, which looks compelling.

Henry Schein: Starting To Look Appealing Again

Henry Schein, Inc. (NASDAQ:HSIC ) Q1 2023 Earnings Conference Call May 9, 2023 10:00 AM ET Company Participants Graham Stanley - VP, IR & Strategic Financial Project Officer Stanley Bergman - Chairman & CEO Ron South - SVP & CFO Conference Call Participants Jason Bednar - Piper Sandler Nathan Rich - Goldman Sachs A.J. Rice - Credit Suisse Jeff Johnson - Baird Jon Block - Stifel Elizabeth Anderson - Evercore ISI Kevin Caliendo - UBS Brandon Vazquez - William Blair Erin Wright - Morgan Stanley Operator Good morning, ladies and gentlemen, and welcome to Henry Schein's First Quarter 2023 Earnings Conference Call.

Henry Schein, Inc. (HSIC) Q1 2023 Earnings Call Transcript

Henry Schein's (HSIC) first-quarter results largely reflect lower contributions from the sales of PPE products and COVID-19 test kits.

Henry Schein (HSIC) Q1 Earnings Miss, Operating Margin Dips

Henry Schein (HSIC) came out with quarterly earnings of $1.21 per share, missing the Zacks Consensus Estimate of $1.24 per share. This compares to earnings of $1.30 per share a year ago.

Henry Schein (HSIC) Q1 Earnings and Revenues Miss Estimates

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein reports first-quarter 2023 financial results.

Henry Schein Reports First-Quarter 2023 Financial Results

Henry Schein (HSIC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Why Earnings Season Could Be Great for Henry Schein (HSIC)

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein acquires Regional Health Care Group, a medical distributor serving the Australia and New Zealand region.

Henry Schein Acquires Regional Health Care Group, a Medical Distributor Serving the Australia and New Zealand Region

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care products and services to office-based dental and medical practitioners, announced an agreement to acquire S.I.N. Implant System, one of Brazil's leading manufacturers of dental implants, pending regulatory approval. With 2022 sales of approximately $61 million, S.I.N. is a growing provider of dental implants in Brazil. Henry Schein has served dental practitioners in Brazil since 2014,.

Henry Schein Signs Definitive Agreement to Acquire S.I.N. Implant System

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Why Henry Schein (HSIC) is a Top Value Stock for the Long-Term

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein Dental Presents: THRIVELIVE 2023.

Henry Schein Dental Presents: THRIVELIVE 2023

Cooper Companies

West Pharmaceutical Services

Here, we discuss three stocks from the Dental Supplies industry that are likely to create wealth for investors. These include WST, COO and HSIC.

3 Dental Supplies Stocks to Buy as Industry Prospects Recover

Bio-Rad Laboratories

Insulet

MedTech companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how BIO, HSIC and PODD are poised ahead of their earnings releases.

3 MedTech Stocks Likely to Beat Estimates in Q1 Earnings

Henry Schein (HSIC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Henry Schein (HSIC) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that it will release its first quarter 2023 financial results before the stock market opens on Tuesday, May 9, 2023, and will provide a live webcast of its earnings conference call on the same day beginning at 10:00 a.m. Eastern time. Speakers on the call will include Stanley M. Bergman, Chairman of the Board.

Henry Schein to Webcast First Quarter 2023 Conference Call on Tuesday, May 9, 2023 at 10:00 A.M. ET

Henry Schein's (HSIC) medical business is expected to have gained from improved U.S. patient traffic to physician offices, ultimate care sites and ambulatory surgical centers.

Henry Schein (HSIC) to Report Q1 Earnings: What's in Store?

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the Bank of America Healthcare Conference at the Encore Hotel in Las Vegas on May 10, 2023, at 1:40 p.m. Pacific time (4:40 p.m. Eastern time). Henry Schein's presentations can be heard via live webcast by visiting www.henryschein.com/IRwebcasts.

Henry Schein to Participate in Bank of America Healthcare Investor Conference

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Are Investors Undervaluing Henry Schein (HSIC) Right Now?

Merit Medical Systems

Investors interested in stocks from the Medical - Dental Supplies sector have probably already heard of Henry Schein (HSIC) and Merit Medical (MMSI). But which of these two stocks offers value investors a better bang for their buck right now?

HSIC or MMSI: Which Is the Better Value Stock Right Now?

Investors are optimistic about Henry Schein (HSIC), led by the strong potential in the company's dental technology joint venture, Henry Schein One.

Here's Why You Should Invest in Henry Schein (HSIC) Now

Crocs

Inter Parfums

CROX, HSIC and IPAR made it to the Zacks Rank #1 (Strong Buy) growth stocks list on April 17, 2023.

Best Growth Stocks to Buy for April 17th

MELVILLE, N.Y.--(BUSINESS WIRE)--In celebration of Earth Day 2023, Henry Schein, Inc. (Nasdaq: HSIC) today announced the launch of Practice Green – a global initiative designed to encourage health care practitioners to become more eco-friendly – in the U.S. and Canada. Practice Green aims to help empower the health care community to establish sustainable practices for a healthier planet.

Henry Schein Champions Sustainable Business Practices With the Launch of Practice Green in North America

Graphic Packaging Hld

CROX, HSIC and and GPK made it to the Zacks Rank #1 (Strong Buy) growth stocks list on April 13, 2023.

Best Growth Stocks to Buy for April 13th

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) today announced its support for the Carry The Load® Memorial May campaign, a month-long Memorial Day awareness program providing active ways to connect Americans to the sacrifices made by the U.S. military, Veterans, first responders, and their families.

News for Henry Schein Stock (HSIC)